H 7185Pharmaceuticals

Businesses and Professions - Protections of Healthcare Providers Act

Allows abortion medication labels to list the healthcare practice's name instead of the individual dispenser's name.

Held for study

Population
Affected

Introduced Jan 21, 2026Committee House Judiciary

Plain-English Summary

This legislation amends the "Protections for Healthcare Providers Act." It allows a healthcare provider who prescribes medication for an abortion to request that the prescription label display the name of the healthcare practice instead of the name of the individual person dispensing the drug. This applies to medications specifically intended to induce the termination of a pregnancy, such as mifepristone and misoprostol. The bill aims to modify labeling requirements for these specific prescriptions.

For younger readers

When a doctor gives a patient medicine, the bottle usually has a sticker that lists the name of the specific person who handed out the medicine. This bill changes the rules for medicine used to end a pregnancy. It says that if the doctor asks, the sticker can show the name of the doctor's office or clinic instead of the specific worker's name. This helps keep the worker's name private.

Who & Where It Applies

Impacted groups

PharmacistsHealthcare PrescribersMedical ClinicsPregnant WomenPharmacy Technicians

Impacted communities

All

Constitutional & Fiscal Check

None Likely

Estimated cost

None

Estimated revenue

None

Bill Analysis

Both viewpoints

For Progressives

Protecting the anonymity of individual healthcare workers dispensing abortion medication reduces the risk of harassment, doxxing, and targeted violence against them.
Strengthens the state's reproductive healthcare infrastructure by ensuring providers feel safer performing their duties, thereby maintaining patient access to care.
Reinforces the "Protections for Healthcare Providers Act," signaling a continued legislative commitment to safeguarding reproductive rights and the workers who facilitate them.
Relies on the prescriber to actively request the anonymity, potentially leaving dispensing staff vulnerable if the prescriber forgets or chooses not to make the request.
Could theoretically make it slightly more difficult for a patient to identify a specific negligent individual in a malpractice situation, though the practice itself remains liable.
Represents a minor administrative adjustment rather than a comprehensive expansion of reproductive healthcare funding or access for marginalized communities.

For Conservatives

Protects the privacy and safety of private citizens working in the healthcare sector, aligning with principles of individual security.
Maintains a voluntary approach by allowing the prescriber to make the request, rather than a heavy-handed government mandate forcing all labels to change.
Allowing the listing of the practice name rather than the individual aligns with corporate liability structures, treating the business entity as the responsible party.
Reduces transparency and accountability in the dispensing of controversial drugs by shielding the specific identity of the pharmacist or dispenser.
Facilitates the distribution of abortion-inducing drugs by removing social accountability and community oversight of individuals participating in the process.
Expands the scope of the "Protections for Healthcare Providers Act," further entrenching abortion protections into state law.

Votes

Loading votes...

Full Bill Text

Changes to existing Rhode Island law · 7 additions

SECTION 1. Chapter 5-37.8 of the General Laws entitled "Protections for Healthcare Providers Act" is hereby amended by adding thereto the following section: 5-37.8-4. Prescriptive protections for providers of legal protected healthcare activity.

(a) Notwithstanding any other provision in this chapter to the contrary, at the prescriber’s request, the prescription label for medication abortion prescription drugs may include the name of the dispensing healthcare practice instead of the name of the dispenser.

(b) For purposes of this section, “medication abortion prescription drugs” means substances used in the course of medical treatment intended to induce the termination of a pregnancy including, but not limited to, mifepristone and misoprostol.

SECTION 2. This act shall take effect upon passage.